ClientJune 24, 2026
GAIA-BT to Lead "AI Optimization" of Cyron Therapeutics' Cancer Drug Candidates
PartnershipMay 20, 2026
GAIA-BT Signs MOU with Korea Institute of Toxicology for Joint R&D
PartnershipMay 20, 2026
GAIA-BT Signs Letter of Intent with Prosilico for AI-Based Drug Discovery Collaboration
PartnershipMay 19, 2026
GAIA-BT Signs Letter of Intent with ProEn Therapeutics for Joint R&D
PartnershipMay 18, 2026
GAIA-BT Signs Letter of Intent with Evidentia Labs for AI-Based Drug Discovery Collaboration
...
